Priority Date: 02.03.12 (US 201261605947P)

THE USE OF A PANEL OF URINARY CYTOKINES TO PREDICT RESPONSE TO BCG THERAPY FOR BLADDER CANCER

  • Application ID: EP13755291
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Vossius & Partner Patentanwälte Rechtsanwälte mbB is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 02.03.2012 - Priority Date (US 201261605947P)
  • 06.09.2013 - Publication A1 (WO2013131093)
  • 07.01.2015 - Publication A1 (EP2819694)